Catalytic inhibition of DNA topoisomerase IIα by sodium azide

Toxicology Letters

Volumn 121, Issue 2, 2001, Pages 119-126

  Ju, Rong ^a   Mao, Yinghui ^a   Glick, Melissa J ^a   Muller, Mark T ^a   Snyder, Ronald D ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b DUPONT COMPANY   (United States)

Author keywords

Azide; ICT assay; Topoisomerase II

Indexed keywords

ADENOSINE TRIPHOSPHATE; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; GYRASE INHIBITOR; SODIUM AZIDE;

ARTICLE; CATALYSIS; COMPLEX FORMATION; CONTROLLED STUDY; DNA CLEAVAGE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INACTIVATION; ENZYME PURIFICATION; ENZYME SUBUNIT; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CATALYSIS; DNA DAMAGE; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; HELA CELLS; HUMANS; ISOENZYMES; SODIUM AZIDE;

EID: 0035971484     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(01)00328-9     Document Type: Article

References (18)

1. Andersen A.H., Svejstrup J.Q., Westergaard O. The DNA binding, cleavage, and religation reactions of eucaryotic topoisomerases I and II. Adv. Pharmacol. 29:1994;83-101.
2. Chung I.K., Spitzner J.R., Muller M.T. Eukaryotic topoisomerase II preferentially cleaves alternating purine repeats. Nucl. Acid. Res. 18:1990;1-6.
3. Hanlin A., Kuan-Chun H., Yamasaki E.F., Chan K.K., Chohan L., Snapka R.M. XK469, a selective topoisomerase II β poison. Proc. Natl. Acad. Sci. (USA). 96:1999;12168-12173.
4. Jensen P.B., Jensen P.S., Demant E.J.F., Friche E., Sorensen B.S., Sehested M., Wassermann K., Vindeloev L., Westergaard O., Hansen H.H. Antagonist effect of aclarubicin on daunorubicin-induced cytotoxicity in human small lung cancer cells: relationship to DNA integrity and topoisomerase II. Cancer Res. 51:1991;5093-5099.
5. Jensen P.B., Sorensen B.S., Sehested M., Grue P., Demant E.G.F., Hansen H.H. Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments. Cancer Res. 54:1994;2959-2963.
6. Kupfer G., Odley A.L.B., Liu L.F. Involvement of intracellular ATP in cytotoxicity of topoisomerase II targeting antitumor drugs. NCI Monographs. 4:1987;37-40.
7. Lock R.B., Thompson B.S., Stribinskiene L. Differential ability of DNP to modulate etoposide cytotoxicity in mammalian tumor cell lines associated with inhibition of macromolecular synthesis. Int. J. Oncol. 8:1996;305-311.
8. Osheroff N., Shelton E.R., Brutlag D.L. DNA topoisomerase II from Drosophila melanogaster: relaxation of supercoiled DNA. J. Biol. Chem. 258:1983;9536-9543.
9. Roca J., Wang J.C. The capture of a DNA double helix by an ATP-dependent protein clamp: A key step in DNA transport by type II DNA topoisomerases. Cell. 71:1992;833-840.
10. Rowe T., Kupfer G., Ross W.E. Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavage. Biochem. Pharmacol. 34:1985;2483-2487.
11. Snyder R.D. Use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells. Env. Mol. Mutagen. 35:2000;13-21.
12. Snyder R.D., Cooper C.S. Photogenotoxicity of fluoroquinolones in Chinese hamster V79 cells: dependency on active topoisomerase II. Photochem. Photobiol. 69:1999;288-293.
13. Snyder R.D., Grdina D.J. Further evidence that the radioprotective aminothiol, WR-1065, catalytically inactivates mammalian topoisomerase II. Cancer Res. 60:2000;1186-1188.
14. Sorensen M., Sehested M., Jensen P.B. Effect of cellular ATP depletion on topoisomerase II poisons: abrogation of cleavable complex formation by etoposide but not by amsacrine. Mol. Pharmacol. 55:1999;424-431.
15. Subramanian D., Rosenstein B., Muller M.T. Ultraviolet-induced DNA damage stimulates topoisomerase-I-DNA complex formation in vivo: Possible relationship with cancer. Cancer Res. 58:1998;976-984.
16. Vailyeva E., Forgac M. Interaction of the clathrin-coated vesicle V-ATPase with ADP and sodium azide. J. Biol. Chem. 273:1998;23823-23829.
17. Wang J.C. DNA Topoisomerases. Annu. Rev. Biochem. 65:1996;635-692.
18. Weber J., Senior A.E. Effects of the inhibitors azide, dicyclohexylcarbodiimide, and auroventin on nucleotide binding to the three F1-ATPase catalytic sites measured using specific tryptophan probes. J. Biol. Chem. 273:1998;33210-33215.